GlassScriptPhysician profile
Brian H Keogh
NPI 1922324078
$23,614.39
in general payments reported to CMS, 2019-2025
42 companies · $6,194 in 2025
The $6,194 reported for 2025 was more than what 96% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,164 · 2020: $355 · 2021: $2,119 · 2022: $3,428 · 2023: $3,794 · 2024: $4,561 · 2025: $6,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,721 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,817.22 |
| Travel and Lodging | $3,720.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,385.68 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Therapies |
| Medtronic, INC. | $4,791.66 | 2021-2025 | Intellis Adaptivestim, Activos 10 Bone Cement, Inceptiv |
| Saluda Medical Americas, INC. | $2,270.50 | 2023-2025 | Evoke, Evoke Scs |
| Biotronik Nro, INC. | $1,680.45 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $1,294.33 | 2019-2025 | Eterna, Proclaim |
| Nevro Corp. | $1,178.78 | 2021-2024 | Senza |
| Relievant Medsystems, INC. | $610.00 | 2019-2023 | Intracept |
| Medtronic USA, INC. | $559.87 | 2019-2020 | |
| Mml US, INC. | $553.94 | 2022-2025 | Reactiv8 |
| Si-Bone, INC. | $505.59 | 2019-2025 | |
| Spr Therapeutics, INC | $491.19 | 2022-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $429.55 | 2022-2025 | Belbuca, Xtampza |
| Globus Medical, INC. | $302.06 | 2025 | Senza |
| Vertos Medical, INC. | $244.50 | 2019-2023 | Mild Device Kit |
| Arbor Pharmaceuticals, INC. | $190.31 | 2020-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $184.82 | 2023-2025 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $180.67 | 2019-2025 | Ztlido |
| Virtus Pharmaceuticals LLC | $164.14 | 2023-2025 | Levorphanol Tartrate |
| Abbvie INC. | $163.25 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $143.35 | 2025 | |
| Pfizer INC. | $139.04 | 2020-2025 | |
| Sonex Health, INC. | $133.66 | 2022 | |
| Stryker Corporation | $132.66 | 2024-2025 | Mild Device Kit, Omnicurve |
| Curonix LLC | $128.85 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.17 | 2023-2025 | Relistor |
| Painteq LLC | $108.28 | 2024 | Painteq |
| Valinor Pharma, LLC | $86.41 | 2024-2025 | Movantik |
| Forte Bio-Pharma LLC | $75.34 | 2025 | Prolate, Nalocet, Tanlor |
| Spinal Simplicity, LLC | $57.87 | 2023-2024 | Ha Minuteman G3-R |
| Bioventus LLC | $47.84 | 2022-2023 | Durolane |
| Biodelivery Sciences International, INC. | $39.15 | 2019-2021 | |
| Tersera Therapeutics LLC | $33.02 | 2025 | Prialt |
| Sentynl Therapeutics, INC. | $31.54 | 2019 | |
| Avanos Medical | $28.14 | 2025 | Trays- All |
| Fidia Pharma USA INC. | $21.24 | 2019 | |
| Redhill Biopharma INC. | $20.78 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.66 | 2022 | |
| Almatica Pharma LLC | $17.58 | 2022 | |
| Depuy Synthes Sales INC. | $15.37 | 2025 | Monovisc, Orthovisc |
| Stimwave Technologies Incorporated | $14.79 | 2022 | |
| Novo Nordisk INC | $14.10 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Keogh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.